IRS2 and non-small cell lung carcinoma: LINC00525 also acts as a ceRNA, for miR-338-3p, increasing NSCLC cell invasion and migration by increasing insulin receptor substrates 2 (IRS2), a signaling adapter protein that is implicated in cancer progression and metastasis [58].